Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. (RAPP) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 58 transactions totaling $16.6M, demonstrating a bullish sentiment with $7.8M in net insider flow. The most recent transaction on Dec 17, 2025 involved a sale of 2,147 shares valued at $61.9K.
RAPP Insider Activity Summary
Who Is Buying RAPP Stock?
No significant insider buying has been recorded for RAPP in the recent period.
Who Is Selling RAPP Stock?
No significant insider selling has been recorded for RAPP in the recent period.
Is Rapport Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RAPP is bullish with an Insider Alignment Score of 74/100 and a net flow of $7.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
RAPP Frequently Asked Questions
Understanding RAPP Insider Activity
Insider trading at Rapport Therapeutics, Inc. (RAPP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading RAPP stock, having executed 58 transactions in the past 90 days. The most active insider is James Healy (Executive), who has made 18 transactions totaling $10.6M.
Related Tools
Track Rapport Therapeutics, Inc. Insider Activity
Get notified when executives and directors at RAPP file new Form 4 transactions